Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study

• Main Authors: Thibaud Mathis (Author), Maxence Papegaey (Author), Cécile Ricard (Author), Amina Rezkallah (Author), Frédéric Matonti (Author), Aditya Sudhalkar (Author), Cristina Vartin (Author), Corinne Dot (Author), Laurent Kodjikian (Author)
• Format: Book
• Published: MDPI AG, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Diabetic macular edema (DME) is the main cause of visual impairment in diabetic patients and a chronic disease requiring long-term treatments. The fluocinolone acetonide (FAc) implant has recently been approved to treat DME in patients considered insufficiently responsive to available therapies. Thi...